BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20933415)

  • 1. Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L.
    Kumar GD; Chavarria GE; Charlton-Sevcik AK; Yoo GK; Song J; Strecker TE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6610-5. PubMed ID: 20933415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors.
    Kishore Kumar GD; Chavarria GE; Charlton-Sevcik AK; Arispe WM; Macdonough MT; Strecker TE; Chen SE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1415-9. PubMed ID: 20089402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial evaluation of the antitumour activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L.
    Chavarria GE; Horsman MR; Arispe WM; Kumar GD; Chen SE; Strecker TE; Parker EN; Chaplin DJ; Pinney KG; Trawick ML
    Eur J Med Chem; 2012 Dec; 58():568-72. PubMed ID: 23168380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex.
    Tsuge H; Nishimura T; Tada Y; Asao T; Turk D; Turk V; Katunuma N
    Biochem Biophys Res Commun; 1999 Dec; 266(2):411-6. PubMed ID: 10600517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural polyprenylated benzophenones inhibiting cysteine and serine proteases.
    Martins FT; Assis DM; Dos Santos MH; Camps I; Veloso MP; Juliano MA; Alves LC; Doriguetto AC
    Eur J Med Chem; 2009 Mar; 44(3):1230-9. PubMed ID: 18995931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule inhibitors of cathepsin L incorporating functionalized ring-fused molecular frameworks.
    Song J; Jones LM; Chavarria GE; Charlton-Sevcik AK; Jantz A; Johansen A; Bayeh L; Soeung V; Snyder LK; Lade SD; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2013 May; 23(9):2801-7. PubMed ID: 23540644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors?
    Torkar A; Lenarčič B; Lah T; Dive V; Devel L
    Bioorg Med Chem Lett; 2013 May; 23(10):2968-73. PubMed ID: 23562595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases.
    Carmona E; Dufour E; Plouffe C; Takebe S; Mason P; Mort JS; Ménard R
    Biochemistry; 1996 Jun; 35(25):8149-57. PubMed ID: 8679567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
    J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of a water-soluble phosphate prodrug salt and structural analogues of KGP94, a lead inhibitor of cathepsin L.
    Parker EN; Odutola SO; Wang Y; Strecker TE; Mukherjee R; Shi Z; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1304-1310. PubMed ID: 28117205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorobenzoyl dipeptidyl derivatives as inhibitors of the Fasciola hepatica cysteine protease cathepsin L1.
    Moran BW; Anderson FP; Ruth DM; Fágáin CO; Dalton JP; Kenny PT
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):1-12. PubMed ID: 20030504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuning and predicting biological affinity: aryl nitriles as cysteine protease inhibitors.
    Ehmke V; Quinsaat JE; Rivera-Fuentes P; Heindl C; Freymond C; Rottmann M; Brun R; Schirmeister T; Diederich F
    Org Biomol Chem; 2012 Aug; 10(30):5764-8. PubMed ID: 22336919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterocyclizations of pregnenolone: novel synthesis of thiosemicarbazone, thiophene, thiazole, thieno[2,3-b]pyridine derivatives and their cytotoxicity evaluations.
    Mohareb RM; Wardakhan WW; Elmegeed GA; Ashour RM
    Steroids; 2012 Dec; 77(14):1560-9. PubMed ID: 23064007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary amides as selective inhibitors of cathepsin K.
    Léger S; Bayly CI; Black WC; Desmarais S; Falgueyret JP; Massé F; Percival MD; Truchon JF
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4328-32. PubMed ID: 17544269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
    Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
    J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
    Löser R; Gütschow M
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.
    Tyagi C; Grover S; Dhanjal J; Goyal S; Goyal M; Grover A
    BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S10. PubMed ID: 24564425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triterpenoids as novel natural inhibitors of human cathepsin L.
    Ramalho SD; De Sousa LR; Nebo L; Maganhi SH; Caracelli I; Zukerman-Schpector J; Lima MI; Alves MF; Da Silva MF; Fernandes JB; Vieira PC
    Chem Biodivers; 2014 Sep; 11(9):1354-63. PubMed ID: 25238076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.